Cutaneous adverse events caused byimmune checkpoint inhibitors:classification and management / 中华放射肿瘤学杂志
Chinese Journal of Radiation Oncology
;
(6): 331-334, 2018.
Artículo
en Chino
| WPRIM
| ID: wpr-708191
ABSTRACT
Immune checkpoint inhibitors(ICPIs)have been successfully used in the treatment of multiple malignancies.However,immune-related adverse events(irAEs)may occur during treatment.Cutaneous adverse event(CAE)is acommon type of irAE. Mild CAEs include maculopapule,lichenoid reaction,bullous pemphigoid,vitiligo,psoriasis,and scleroderma. Severe and even life-threatening CAEs include Steven-Johnson syndromeand toxic epidermal necrolysis. Other CAEs include drug reactionwith eosinophiliaand systemic symptoms,Sweet′s syndrome,alopecia,Grover′s disease, and paraneoplastic syndrome. This paper reviews the treatment of cutaneous adverse events associated with ICPIs.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Chinese Journal of Radiation Oncology
Año:
2018
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS